Sodium Fluorescein
Sodium fluorescein is a fluorescent xanthene dye that emits a yellow-green color under blue (490 nm) or ultraviolet light, visible even at very low concentrations in urine. In GU practice it has a niche role as an IV ureteral-identification agent and as an intravesical leak-detection dye — filling the gap left by indigo carmine shortages and serving as a low-cost alternative to NIR fluorophores in centers without NIR imaging.[1]
Pharmacology
| Property | Value |
|---|---|
| Class | Xanthene fluorescent dye |
| Color | Yellow-green (visible), intensifies under blue/UV light |
| Route | IV or intravesical |
| Renal excretion | Rapid glomerular filtration → visible in urine within 5–15 minutes of IV dose |
| Duration | 30–60 minutes of visible urinary fluorescence |
| FDA approval | FLUORESCITE: retinal/iris angiography or angioscopy; GU use is off-label, not approved “by extension” |
GU Applications
1. IV ureteral identification during MIS / open pelvic surgery
- 25–50 mg IV (diluted) produces visible yellow-green urinary efflux within 5–15 minutes
- Particularly useful when indigo carmine is unavailable and NIR imaging is not in place
- Doyle et al. 2015 described 25–100 mg IV for ureteral efflux; the later Grimes randomized trial used 25 mg. These are off-label study regimens, not the labeled ophthalmic dose.[1][2]
2. Intravesical applications
Intravesical use is off-label and lacks a standardized regimen established by the cited IV-efflux studies. Do not transfer an IV or ophthalmic preparation into the bladder without an appropriate local protocol and pharmacy review.
3. Perfusion / angiography (limited GU use)
- Widely used in ophthalmology for retinal angiography
- Occasional intraoperative use for flap perfusion assessment in plastic surgery
- Rare in GU reconstruction (ICG preferred for perfusion)
Dosing
- IV ureteral identification: 25–50 mg IV (dilute in 10 mL saline, give slowly)
- Intravesical leak testing: use a locally reviewed protocol; the IV studies do not establish a bladder dose.
- Verify the supplied concentration: FLUORESCITE 10% is 100 mg/mL. GU studies used much less than the labeled 500 mg adult ophthalmic dose.[3]
Adverse Events
- Skin yellowing — transient
- Yellow urine — expected, resolves in 24 hours
- Nausea, vomiting — occasional at higher doses
- Hypersensitivity, including fatal anaphylaxis — known fluorescein/component hypersensitivity is a contraindication; low-dose GU use does not establish freedom from this risk. Have emergency treatment available.
- Extravasation can cause severe tissue damage; confirm a functioning IV.[3]
- Fluorescent/colorimetric assays may be affected; notify the laboratory of recent dye administration
Sodium Fluorescein vs. Indigo Carmine vs. Methylene Blue
| Feature | Sodium Fluorescein | Indigo Carmine | Methylene Blue |
|---|---|---|---|
| Color | Yellow-green | Blue-violet | Deep blue |
| Visible in urine | Yes (enhanced under UV/blue) | Yes | Yes |
| Best use | Alternative to indigo carmine when unavailable | Cystoscopic ureteral-efflux aid | Fistula / orifice / anastomotic leak |
| Availability | Consistent | BLUDIGO marketed; check local supply | Consistent |
| Cost | Low | Low | Very low |
| Need for special imaging | Enhanced by blue filter (optional) | None | None |
See Also
References
1. Doyle PJ, Lipetskaia L, Duecy E, Buchsbaum G, Wood RW. Sodium fluorescein use during intraoperative cystoscopy. Obstet Gynecol. 2015;125(3):548–550. doi:10.1097/AOG.0000000000000675
2. Grimes CL, Patankar S, Ryntz T, et al. Evaluating ureteral patency in the post-indigo carmine era: a randomized controlled trial. Am J Obstet Gynecol. 2017;217(5):601.e1–601.e10. doi:10.1016/j.ajog.2017.07.012.
3. FLUORESCITE. US prescribing information, revised June 2026. DailyMed.